ArticleTrials2022

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis.

Ruth L Goodall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.